+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

From
North America Genomics Market Outlook, 2030 - Product Thumbnail Image

North America Genomics Market Outlook, 2030

  • Report
  • June 2025
  • 88 Pages
  • North America
From
Antibody Drug Conjugates Market Report 2025-2035 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2025-2035

  • Report
  • December 2024
  • 342 Pages
  • Global
From
From
Precision Medicine Software Market - Focused Insights 2024-2029 - Product Thumbnail Image

Precision Medicine Software Market - Focused Insights 2024-2029

  • Report
  • October 2024
  • 141 Pages
  • Global
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
From
The Chinese Market for DNA Sequencing - Product Thumbnail Image

The Chinese Market for DNA Sequencing

  • Report
  • September 2025
  • 82 Pages
  • China
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more